Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of 124I-p5+14 Injection as an Imaging Agent for the Detection of Systemic Amyloidosis

NCT03678259 is registered in ClinicalTrials.gov with University of Tennessee Graduate School of Medicine as lead sponsor.

NCT NCT03678259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03678259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of 124I-p5+14 Injection as an Imaging Agent for the Detection of Systemic Amyloidosis
Lead sponsor
University of Tennessee Graduate School of Medicine
Phase
Phase 1/2
Overall status
Completed
Start date
October 1, 2018
Completion date
October 1, 2021
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic amyloidosis